GB9312761D0
(en)
*
|
1993-06-21 |
1993-08-04 |
Wellcome Found |
Amino acid derivatives
|
US5424447A
(en)
*
|
1993-07-07 |
1995-06-13 |
The Medical College Of Wisconsin Research Foundation, Inc. |
Heme binding compounds and use thereof
|
DE69432019T2
(de)
*
|
1993-08-12 |
2003-11-27 |
Astrazeneca Ab |
Amidin-derivate mit stickstoffoxid-synthease-aktivität
|
CN1071746C
(zh)
*
|
1993-08-12 |
2001-09-26 |
阿斯特拉公司 |
具有氧化氮合成酶活性的脒衍生物
|
US6225305B1
(en)
|
1993-10-04 |
2001-05-01 |
Glaxo Wellcome Inc. |
Substituted urea and isothiorea derivatives as no synthase inhibitors
|
US6297276B1
(en)
|
1993-10-04 |
2001-10-02 |
Glaxosmithkline |
Substituted urea and isothiourea derivatives as no synthase inhibitors
|
ATE222100T1
(de)
*
|
1993-10-21 |
2002-08-15 |
Searle & Co |
Amidino-derivate nützlich als no synthase-hemmer
|
DE69416848T2
(de)
|
1993-10-21 |
1999-07-08 |
Searle & Co |
Amidino-derivate als no-synthetase inhibitoren
|
DE4337906A1
(de)
*
|
1993-11-08 |
1995-05-11 |
Cassella Ag |
Verwendung von Cumarinderivaten
|
AU1209995A
(en)
*
|
1993-11-17 |
1995-06-06 |
Duke University Medical Center |
Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
|
GB9326136D0
(en)
*
|
1993-12-22 |
1994-02-23 |
Erba Carlo Spa |
Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
|
GB9404400D0
(en)
*
|
1994-03-07 |
1994-04-20 |
Wood Pauline J |
Potentiation of bioreductive agents
|
WO1995024382A1
(en)
*
|
1994-03-10 |
1995-09-14 |
G.D. Searle & Co. |
L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors
|
PT751930E
(pt)
*
|
1994-03-24 |
2000-04-28 |
Searle & Co |
Derivados amidino uteis como inibidores da sintetase de oxido nitrico
|
ATE182889T1
(de)
*
|
1994-05-07 |
1999-08-15 |
Astra Ab |
Bicyclische amidinderivate als no-synthetase inhibitoren
|
JP2989010B2
(ja)
|
1994-06-15 |
1999-12-13 |
ザ、ウェルカム、ファンデーション、リミテッド |
酵素阻害剤
|
CA2132690A1
(en)
*
|
1994-09-22 |
1996-03-23 |
Dean Willis |
Control and modulation of inflammatory response in humans in need of such control and modulation
|
US6066333A
(en)
*
|
1994-09-22 |
2000-05-23 |
William Harvey Research Limited |
Pharmaceutical control of inflammation
|
AU723677B2
(en)
*
|
1994-09-22 |
2000-08-31 |
William Harvey Research Limited |
Pharmaceutical control of inflammation
|
US5684008A
(en)
*
|
1994-11-09 |
1997-11-04 |
G. D. Searle & Co. |
Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
|
FR2727111B1
(fr)
*
|
1994-11-21 |
1997-01-17 |
Hoechst Lab |
Nouveaux analogues soufres d'aminoacides, leur procede de preparation et leurs applications comme medicaments
|
JPH08333258A
(ja)
|
1994-12-14 |
1996-12-17 |
Japan Tobacco Inc |
チアジン又はチアゼピン誘導体及びそれら化合物を含有してなる一酸化窒素合成酵素阻害剤
|
GB9425701D0
(en)
*
|
1994-12-20 |
1995-02-22 |
Wellcome Found |
Enzyme inhibitors
|
WO1996021445A1
(en)
*
|
1995-01-13 |
1996-07-18 |
The General Hospital Corporation |
Methods of inhibiting neurodegenerative diseases
|
ES2206571T3
(es)
*
|
1995-04-20 |
2004-05-16 |
G.D. SEARLE & CO. |
Agentes de amidino ciclico utiles como inhibidores de la oxido nitrico sintasa.
|
US5830917A
(en)
*
|
1995-09-11 |
1998-11-03 |
G. D. Searle & Co. |
L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors
|
US5908842A
(en)
*
|
1995-12-08 |
1999-06-01 |
Merck & Co., Inc. |
Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
|
US5945408A
(en)
*
|
1996-03-06 |
1999-08-31 |
G.D. Searle & Co. |
Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
|
US5981511A
(en)
*
|
1996-03-06 |
1999-11-09 |
G.D. Searle & Co. |
Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
|
US6043218A
(en)
*
|
1996-10-22 |
2000-03-28 |
Medical University Of South Carolina |
Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
|
US6566330B1
(en)
|
1996-10-22 |
2003-05-20 |
Medical University Of South Carolina Foundation Research Development |
Positively charged non-natural amino acids, methods of making and using thereof in peptides
|
US6160000A
(en)
*
|
1996-12-23 |
2000-12-12 |
Merck & Co., Inc. |
Antidiabetic agents based on aryl and heteroarylacetic acids
|
US6090839A
(en)
*
|
1996-12-23 |
2000-07-18 |
Merck & Co., Inc. |
Antidiabetic agents
|
US6369272B1
(en)
|
1997-01-13 |
2002-04-09 |
Glaxosmithkline |
Nitric oxide synthase inhibitors
|
US6620848B2
(en)
|
1997-01-13 |
2003-09-16 |
Smithkline Beecham Corporation |
Nitric oxide synthase inhibitors
|
MY117948A
(en)
*
|
1997-01-13 |
2004-08-30 |
Glaxo Group Ltd |
Nitride oxide synthase inhibitors.
|
FR2764889B1
(fr)
*
|
1997-06-20 |
2000-09-01 |
Sod Conseils Rech Applic |
Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
|
JP4856295B2
(ja)
*
|
1997-07-03 |
2012-01-18 |
アメリカ合衆国政府 |
新規な一酸化窒素放出アミジン誘導ジアゼニウムジオレート及びその組成物
|
US5981556A
(en)
*
|
1997-07-22 |
1999-11-09 |
G.D. Searle & Co. |
1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
|
OA11901A
(en)
*
|
1998-03-11 |
2006-04-10 |
Searle & Co |
Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors.
|
US6673807B1
(en)
*
|
1998-04-06 |
2004-01-06 |
Fujisawa Pharmaceutical Co., Ltd. |
Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins
|
GB9811599D0
(en)
|
1998-05-30 |
1998-07-29 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
US6552052B2
(en)
|
1998-06-10 |
2003-04-22 |
Monsanto/G.D. Searle |
Pyrrolo[2,1-c][1,2,4] thiadiazoles and Pyrollo[2,1-c][1,12,4]oxadiazoles useful as nitric oxide synthase inhibitors
|
EP1086108A1
(en)
|
1998-06-10 |
2001-03-28 |
G.D. Searle & Co. |
Heterobicyclic and tricyclic nitric oxide synthase inhibitors
|
PL346860A1
(en)
|
1998-09-08 |
2002-03-11 |
Monsanto Co |
Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors
|
WO2000044731A1
(en)
*
|
1999-01-27 |
2000-08-03 |
G.D. Searle & Co. |
Novel hydroxyamidino carboxylate derivatives useful as nitric oxide synthase inhibitors
|
JP4205340B2
(ja)
|
2000-03-24 |
2009-01-07 |
ファルマシア コーポレーション |
酸化窒素シンターゼ阻害剤として有用なアミジノ化合物およびその塩
|
AR030416A1
(es)
|
2000-04-13 |
2003-08-20 |
Pharmacia Corp |
COMPUESTO DERIVADO HALOGENADO DEL ACIDO 2-AMINO-3,4 HEPTENOICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE Y SU USO EN LA FABRICACION DE UN MEDICAMENTO uTIL COMO INHIBIDOR DE LA OXIDO NITRICO SINTETASA
|
US6787668B2
(en)
|
2000-04-13 |
2004-09-07 |
Pharmacia Corporation |
2-amino-4,5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
|
US6956131B2
(en)
|
2000-04-13 |
2005-10-18 |
Pharmacia Corporation |
2-amino-3, 4 heptenoic compounds useful as nitric oxide synthase inhibitors
|
US6545170B2
(en)
|
2000-04-13 |
2003-04-08 |
Pharmacia Corporation |
2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
|
AR032318A1
(es)
*
|
2000-04-13 |
2003-11-05 |
Pharmacia Corp |
Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
|
AR034120A1
(es)
|
2000-04-13 |
2004-02-04 |
Pharmacia Corp |
Compuesto derivado halogenado del acido 2-amino-4,5 heptenoico, composicion farmaceutica que lo comprende y el uso de dicho compuesto y dicha composicion en la fabricacion de un medicamento para inhibir o modular la sintesis de acido nitrico
|
US6344473B1
(en)
|
2000-08-07 |
2002-02-05 |
G.D. Searle & Co. |
Imidazoles useful as nitric oxide synthase inhibitors
|
AR031608A1
(es)
*
|
2000-09-15 |
2003-09-24 |
Pharmacia Corp |
Derivados de los acidos 2-amino-2-alquil-3-hexenoico y -hexinoico utiles como inhibidores de oxido nitrico sintetasa
|
AR031129A1
(es)
|
2000-09-15 |
2003-09-10 |
Pharmacia Corp |
Derivados de los acidos 2-amino-2-alquil-4-hexenoico y -hexinoico utiles como inhibidores de oxido nitrico sintetasa
|
AR030741A1
(es)
*
|
2000-09-15 |
2003-09-03 |
Pharmacia Corp |
Derivados de los acidos 2-amino-2-alquil-5-heptenoico y - heptinoico utiles como inhibidores de oxido nitrico sintetasa
|
ITTO20010110A1
(it)
|
2001-02-08 |
2002-08-08 |
Rotta Research Lab |
Nuovi derivati benzamidinici dotati di attivita' anti-infiammatoria ed immunosoppressiva.
|
US7012098B2
(en)
*
|
2001-03-23 |
2006-03-14 |
Pharmacia Corporation |
Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
|
US6673338B1
(en)
|
2001-09-10 |
2004-01-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nitric oxide-releasing imidate and thioimidate diazeniumdiolates, compositions, uses thereof and method of making same
|
US20030109522A1
(en)
*
|
2001-09-24 |
2003-06-12 |
Manning Pamela T. |
Ophthalmologic treatment methods using selective iNOS inhibitors
|
US6949530B2
(en)
|
2002-07-18 |
2005-09-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same
|
EP1528921A2
(en)
*
|
2002-08-02 |
2005-05-11 |
Pharmacia Corporation |
Methods for treatment and prevention of gastrointestinal conditions
|
PL375557A1
(en)
|
2002-08-23 |
2005-11-28 |
Pharmacia Corporation |
Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
JP4630820B2
(ja)
|
2003-12-30 |
2011-02-09 |
ヴァソファーム ゲーエムベーハー |
4−アミノ−7,8−ジヒドロプテリジン類、これらを含む医薬組成物、および一酸化窒素レベル上昇によってもたらされる疾病の治療に対するそれらの使用
|
AR049384A1
(es)
|
2004-05-24 |
2006-07-26 |
Glaxo Group Ltd |
Derivados de purina
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
GB0418045D0
(en)
|
2004-08-12 |
2004-09-15 |
Glaxo Group Ltd |
Compounds
|
ATE517908T1
(de)
|
2005-01-10 |
2011-08-15 |
Glaxo Group Ltd |
Androstan-17-alpha-carbonat-derivate zur verwendung bei der behandlung allergischer und entzündlicher zustände
|
PE20061193A1
(es)
|
2005-03-25 |
2006-12-02 |
Glaxo Group Ltd |
DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38
|
UY29440A1
(es)
|
2005-03-25 |
2006-10-02 |
Glaxo Group Ltd |
Nuevos compuestos
|
GB0514809D0
(en)
|
2005-07-19 |
2005-08-24 |
Glaxo Group Ltd |
Compounds
|
TW200730498A
(en)
|
2005-12-20 |
2007-08-16 |
Glaxo Group Ltd |
Compounds
|
BRPI0710240A2
(pt)
|
2006-04-20 |
2011-08-09 |
Glaxo Group Ltd |
composto, uso de um composto, método para o tratamento de um paciente humano ou animal com uma condição ou doença, composição farmacêutica, combinação, e, processo para a preparação de um composto
|
GB0611587D0
(en)
|
2006-06-12 |
2006-07-19 |
Glaxo Group Ltd |
Novel compounds
|
DK2046787T3
(da)
|
2006-08-01 |
2011-07-18 |
Glaxo Group Ltd |
Pyrazolo[3,4-B]pyridin-forbindelser, og deres anvendelse som PDE4-inhibitorer
|
AR065804A1
(es)
|
2007-03-23 |
2009-07-01 |
Smithkline Beecham Corp |
Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
|
KR20160129109A
(ko)
|
2008-05-23 |
2016-11-08 |
아미라 파마슈티칼스 인코포레이티드 |
5-리폭시게나아제 활성화 단백질 억제제
|
WO2009147187A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
4-carboxamide indazole derivatives useful as inhibitors of p13-kinases
|
JP5502077B2
(ja)
|
2008-06-05 |
2014-05-28 |
グラクソ グループ リミテッド |
新規な化合物
|
WO2010094643A1
(en)
|
2009-02-17 |
2010-08-26 |
Glaxo Group Limited |
Quinoline derivatives and their uses for rhinitis and urticaria
|
EP2406255B1
(en)
|
2009-03-09 |
2015-04-29 |
Glaxo Group Limited |
4-oxadiazol-2-yl-indazoles as inhibitors of pi3 kinases
|
JP2012520257A
(ja)
|
2009-03-10 |
2012-09-06 |
グラクソ グループ リミテッド |
Ikk2阻害剤としてのインドール誘導体
|
EP2408769A1
(en)
|
2009-03-17 |
2012-01-25 |
Glaxo Group Limited |
Pyrimidine derivatives used as itk inhibitors
|
CN102439151A
(zh)
|
2009-03-19 |
2012-05-02 |
默沙东公司 |
使用短干扰核酸(siNA)的RNA干扰介导的BTB和CNC同系物1,碱性亮氨酸拉链转录因子1(Bach1)基因表达的抑制
|
JP2012520683A
(ja)
|
2009-03-19 |
2012-09-10 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸(siNA)を用いた結合組織増殖因子(CTGF)遺伝子発現のRNA干渉媒介性阻害
|
JP2012520686A
(ja)
|
2009-03-19 |
2012-09-10 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸(siNA)を用いたシグナル伝達性転写因子6(STAT6)遺伝子発現のRNA干渉媒介性阻害
|
WO2010107957A2
(en)
|
2009-03-19 |
2010-09-23 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
WO2010111464A1
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
JP2012521764A
(ja)
|
2009-03-27 |
2012-09-20 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸(siNA)を用いた胸腺間質性リンパ球新生因子(TSLP)遺伝子発現のRNA干渉媒介性阻害
|
EP2411018A2
(en)
|
2009-03-27 |
2012-02-01 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
|
WO2010111471A2
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
SG174581A1
(en)
|
2009-03-27 |
2011-10-28 |
Merck Sharp & Dohme |
RNA INTERFERENCE MEDIATED INHIBITION OF THE INTERCELLULAR ADHESION MOLECULE 1 (ICAM-1)GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
JP2012524754A
(ja)
|
2009-04-24 |
2012-10-18 |
グラクソ グループ リミテッド |
Cracチャネル阻害剤としてのピラゾールおよびトリアゾ−ルカルボキサミド
|
US8399436B2
(en)
|
2009-04-24 |
2013-03-19 |
Glaxo Group Limited |
N-pyrazolyl carboxamides as CRAC channel inhibitors
|
JO3025B1
(ar)
|
2009-04-30 |
2016-09-05 |
Glaxo Group Ltd |
الأندازولات المستبدلة بالأوكسازول كمثبطات كيناز pi3
|
JP2013512879A
(ja)
|
2009-12-03 |
2013-04-18 |
グラクソ グループ リミテッド |
Pi3キナーゼの阻害剤としてのベンズピラゾール誘導体
|
EP2507226A1
(en)
|
2009-12-03 |
2012-10-10 |
Glaxo Group Limited |
Novel compounds
|
JP2013512880A
(ja)
|
2009-12-03 |
2013-04-18 |
グラクソ グループ リミテッド |
Pi3−キナーゼ阻害剤としてのインダゾール誘導体
|
WO2011084316A2
(en)
|
2009-12-16 |
2011-07-14 |
3M Innovative Properties Company |
Formulations and methods for controlling mdi particle size delivery
|
WO2011110575A1
(en)
|
2010-03-11 |
2011-09-15 |
Glaxo Group Limited |
Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
ES2602972T3
(es)
|
2010-09-08 |
2017-02-23 |
Glaxosmithkline Intellectual Property Development Limited |
Derivados de indazol para su uso en el tratamiento de infección por virus de la gripe
|
DK2614058T3
(en)
|
2010-09-08 |
2015-09-28 |
Glaxosmithkline Ip Dev Ltd |
Polymorphs, and the salts of N- [5- [4- (5 - {[(2R, 6S) -2,6-dimethyl-4-morpholinyl] methyl} -1,3-oxazol-2-yl) -1H-indazole -6-yl] -2- (methyloxy) -3-pyridinyl] methanesulfonamide.
|
WO2012035055A1
(en)
|
2010-09-17 |
2012-03-22 |
Glaxo Group Limited |
Novel compounds
|
JP5795643B2
(ja)
|
2010-10-21 |
2015-10-14 |
グラクソ グループ リミテッドGlaxo Group Limited |
アレルギー性状態、免疫性状態及び炎症性状態に作用するピラゾール化合物
|
US9149462B2
(en)
|
2010-10-21 |
2015-10-06 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, inflammatory and immune disorders
|
GB201018124D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Polymorphs and salts
|
EP2683716A1
(en)
|
2011-03-11 |
2014-01-15 |
Glaxo Group Limited |
Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
BR112016003229A8
(pt)
|
2013-09-22 |
2020-02-04 |
Calitor Sciences Llc |
composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica
|
WO2015148867A1
(en)
|
2014-03-28 |
2015-10-01 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
CN107072976A
(zh)
|
2014-05-12 |
2017-08-18 |
葛兰素史克知识产权第二有限公司 |
用于治疗传染性疾病的包含Danirixin的药物组合物
|
WO2017044434A1
(en)
|
2015-09-11 |
2017-03-16 |
Sunshine Lake Pharma Co., Ltd. |
Substituted heteroaryl compounds and methods of use
|
JP7254076B2
(ja)
|
2017-11-19 |
2023-04-07 |
サンシャイン・レイク・ファーマ・カンパニー・リミテッド |
置換ヘテロアリール化合物及び使用方法
|
WO2019143874A1
(en)
|
2018-01-20 |
2019-07-25 |
Sunshine Lake Pharma Co., Ltd. |
Substituted aminopyrimidine compounds and methods of use
|
EP4125919A1
(en)
|
2020-03-26 |
2023-02-08 |
GlaxoSmithKline Intellectual Property Development Limited |
Cathepsin inhibitors for preventing or treating viral infections
|